No image available for this title

LITERATURE

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial


Treatments for open-angle glaucoma aim to prevent vision loss through lowering of intraocular pressure,
but to our knowledge no placebo-controlled trials have assessed visual function preservation, and the observation
periods of previous (unmasked) trials have typically been at least 5 years. We assessed vision preservation in patients
given latanoprost compared with those given placebo


Availability

Lacoma-005Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Lancet 2015; 385: 1295–304
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous